Other investigators have shown that EGF increases NRP-1 expression in human malignant astrocytoma cell lines and that the expression of NRP-1 mRNA peaks at 4 h and returns to basal levels 8 h after EGF treatment (Ding et al, 2000). This evidence concerns the gene NRP1 and astrocytoma (excluding glioblastoma).